|69.92||+0.4800||+0.69%||Vol 173.47K||1Y Perf 45.16%|
|Apr 13th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||65.67||Analyst Rating||Moderate Buy 2.42|
|Potential %||-6.08||Finscreener Ranking||★+ 44.29|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 48.20|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 55.13|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||5.90B||Earnings Rating||Sell|
|Price Range Ratio 52W %||95.14||Earnings Date||28th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||28th Apr 2021|
|Estimated EPS Next Report||0.56|
|EPS Growth Next 5 Years %||13.20|
|Avg. Weekly Volume||321.53K|
|Avg. Monthly Volume||328.12K|
|Avg. Quarterly Volume||367.90K|
Integra LifeSciences Holdings Corporation (NASDAQ: IART) stock closed at 69.92 per share at the end of the most recent trading day (a 0.69% change compared to the prior day closing price) with a volume of 278.80K shares and market capitalization of 5.90B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3700 people. Integra LifeSciences Holdings Corporation CEO is Peter J. Arduini.
The one-year performance of Integra LifeSciences Holdings Corporation stock is 45.16%, while year-to-date (YTD) performance is 7.7%. IART stock has a five-year performance of 109.81%. Its 52-week range is between 42.12 and 71.34, which gives IART stock a 52-week price range ratio of 95.14%
Integra LifeSciences Holdings Corporation currently has a PE ratio of 44.10, a price-to-book (PB) ratio of 3.87, a price-to-sale (PS) ratio of 5.77, a price to cashflow ratio of 29.00, a PEG ratio of 2.32, a ROA of 3.71%, a ROC of 3.25% and a ROE of 8.76%. The company’s profit margin is 12.63%, its EBITDA margin is 20.50%, and its revenue ttm is $1.02 Billion , which makes it $12.04 revenue per share.
Of the last four earnings reports from Integra LifeSciences Holdings Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.56 for the next earnings report. Integra LifeSciences Holdings Corporation’s next earnings report date is 28th Apr 2021.
The consensus rating of Wall Street analysts for Integra LifeSciences Holdings Corporation is Moderate Buy (2.42), with a target price of $65.67, which is -6.08% compared to the current price. The earnings rating for Integra LifeSciences Holdings Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Integra LifeSciences Holdings Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Integra LifeSciences Holdings Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 7.57, ATR14 : 2.50, CCI20 : 104.90, Chaikin Money Flow : 0.08, MACD : 0.12, Money Flow Index : 46.46, ROC : 5.72, RSI : 46.25, STOCH (14,3) : 89.59, STOCH RSI : 0.76, UO : 67.40, Williams %R : -10.41), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Integra LifeSciences Holdings Corporation in the last 12-months were: Daniel L. Reuvers (Option Excercise at a value of $862 601), Daniel L. Reuvers (Sold 23 330 shares of value $1 226 925 ), Eric I. Schwartz (Sold 6 500 shares of value $450 092 ), Glenn G. Coleman (Sold 22 000 shares of value $1 186 735 ), Jeffrey A. Mosebrook (Sold 1 865 shares of value $114 393 ), Jeffrey Mosebrook (Sold 1 614 shares of value $83 418 ), Lisa Evoli (Option Excercise at a value of $255 627), Lisa Evoli (Sold 18 155 shares of value $978 277 ), Michael McBreen (Sold 2 205 shares of value $152 145 ), Peter J. Arduini (Option Excercise at a value of $1 070 341), Peter J. Arduini (Sold 67 786 shares of value $4 296 222 ), Raymond G. Murphy (Sold 2 839 shares of value $150 921 ), Richard E. Caruso (Option Excercise at a value of $432 525), Richard E. Caruso (Sold 600 000 shares of value $29 082 000 ), Robert T. Davis (Sold 24 941 shares of value $1 732 963 ), Stuart M. Essig (Sold 514 551 shares of value $30 260 146 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.